Clotrimazole topical - CPEX Pharmaceuticals
Alternative Names: Antifungal nail lacquer; OnycofitexLatest Information Update: 02 Oct 2021
At a glance
- Originator Bentley Pharmaceuticals
- Developer CPEX Pharmaceuticals
- Class Antifungals; Chlorobenzenes; Imidazoles; Small molecules
- Mechanism of Action 14-alpha demethylase inhibitors; Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Onychomycosis
Most Recent Events
- 11 Aug 2008 Discontinued - Phase-II for Onychomycosis in USA (Topical)
- 23 Jul 2008 Bentley Pharmaceuticals has been acquired by Teva Pharmaceutical Industries
- 29 Aug 2005 Phase-II clinical trials in Onychomycosis in USA (Topical)